You are here

  • Home
  • Archive
  • Volume 74, Issue 2
  • Clinical implementation of circulating tumour DNA testing for EGFR T790M for detection of treatment resistance in non-small cell lung cancer

Article info

Article menu

Download PDFPDF

Original research
Clinical implementation of circulating tumour DNA testing for EGFR T790M for detection of treatment resistance in non-small cell lung cancer

Authors

  • Tara Spence Division of Clinical Laboratory Genetics, University Health Network, Toronto, Ontario, Canada Advanced Molecular Diagnostics Laboratory, University Health Network, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Sheron Perera Department of Medical Oncology, University Health Network, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Jessica Weiss Department of Biostatistics, University Health Network, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Sylvie Grenier Division of Clinical Laboratory Genetics, University Health Network, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Laura Ranich Division of Clinical Laboratory Genetics, University Health Network, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Frances Shepherd Department of Medical Oncology, University Health Network, Toronto, Ontario, Canada Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Tracy L Stockley Division of Clinical Laboratory Genetics, University Health Network, Toronto, Ontario, Canada Advanced Molecular Diagnostics Laboratory, University Health Network, Toronto, Ontario, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Tracy L Stockley, Clinical Laboratory Genetics, University Health Network, Toronto, ON M5G 2C4, Canada; Tracy.stockley{at}uhn.ca
View Full Text

Citation

Spence T, Perera S, Weiss J, et al
Clinical implementation of circulating tumour DNA testing for EGFR T790M for detection of treatment resistance in non-small cell lung cancer
Journal of Clinical Pathology 2021;74:91-97.

Publication history

  • Received April 17, 2020
  • Revised May 6, 2020
  • Accepted May 7, 2020
  • First published May 29, 2020.
Online issue publication 
January 27, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.